@TomDanne

18 posts

@TomDanne banner
@TomDanne

@TomDanne

@TomDanne

Prof. Dr. Thomas Danne is a Pediatric Diabetologist and Clinical Researcher with special emphasis on disease modifying therapies for type 1 diabetes

Lisboa, Portugal Katılım Ağustos 2012
29 Takip Edilen321 Takipçiler
Breakthrough T1D
Breakthrough T1D@BreakthroughT1D·
Same mission, New name. Breakthrough T1D (formerly JDRF) is the world leader in T1D research, advocacy, and community support. Our new brand reflects our bold vision for a world without T1D. We are accelerating breakthroughs and building a movement for change. #BreakthroughT1D
English
11
46
105
23.7K
@TomDanne
@TomDanne@TomDanne·
The #SWEET worldwide Pediatric Diabetes Registry Group meets for the first time F2F since 2 years prior to #ATTD in Barcelona #ISPAD
@TomDanne tweet media
English
2
1
30
0
@TomDanne retweetledi
Anja Reschke
Anja Reschke@AnjaReschke1·
Nach den Angriffen sind die Insulinlagerbestände in der Ukraine fast komplett zerstört worden. Erkrankte mit Typ 1 Diabetes überleben ohne keine 3 Tage. Diese Initiative versucht Insulin an eine große Klinik mit vielen betroffenen Kindern zu bringen, um sie behandeln zu können
Anja Reschke tweet media
Deutsch
9
49
124
0
@TomDanne retweetledi
kelly close
kelly close@kellyclose·
#timeinrange has so helped me better understand my A1c + how to improve it ... join @TomDanne + me tomorrow as we spread the word on the power of what these numbers can help us do and feel and be in #diabetes. ❤️
Novo Nordisk Live@NovoNordiskLive

Join us on 21 September at 19.00 CEST where #diabetes patient advocate @KellyClose and Prof @TomDanne discuss the concept of #TimeInRange and why it is so important for people living with diabetes 💙 #EASD2020 #DiaTribeFoundation #NovoNordisk #Abbott

San Francisco, CA 🇺🇸 English
0
3
17
0
@TomDanne
@TomDanne@TomDanne·
ADA 2019: Balanced discussion on risk and benefits of SGLT inhibitors for T1D. Many good reasons to use them with caution! youtu.be/nArp3tbFRfo
YouTube video
YouTube
English
0
0
4
0
@TomDanne
@TomDanne@TomDanne·
Dapagliflozin first drug to be approved for adjunct Type 1 Diabetes therapy in Europe. A milestone nearly 100 years after insulin ema.europa.eu/documents/pres…
English
0
4
5
0
@TomDanne
@TomDanne@TomDanne·
Thomas Müller vom G-BA: wir müssen uns um die Zulassung der künstlichen Bauchspeicheldrüse kümmern #digiatlisierung #diabetes
@TomDanne tweet media
Deutsch
0
0
0
0